Literature DB >> 20942790

Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease.

Odete A B da Cruz e Silva1, Ana Gabriela Henriques, Sara Catarina Timóteo Santos Domingues, Edgar F da Cruz e Silva.   

Abstract

One of the most important contributions to our understanding of neurodegenerative diseases in the last decade has been the demonstration that several disorders have a common biochemical cause, involving aggregation and deposition of abnormal proteins. Abnormal protein deposition leads to neuronal degeneration with consequences to impaired brain function. Protein deposition can be extracellular (beta-amyloid peptide (A beta), prion protein) or intracellular (Tau, alpha-synuclein, huntingtin). Individuals with Alzheimer's disease (AD) exhibit extracellular senile plaques (SPs) of aggregated A beta and intracellular neurofibrillary tangles that contain hyperphosphorylated Tau protein (NFTs), and also an extensive loss in basal forebrain cholinergic neurons that innervate the hippocampus and neocortex. The SPs and NFTs contribute to neurodegeneration, although the mechanisms inducing basal forebrain cholinergic cell loss and cognitive impairment remain unclear. Furthermore, the pathophysiological relationship between NFTs and SPs remains undefined, and controversy still rages over which of the two hallmark pathologies of AD is the primary cause of neurodegeneration in the brain. However, consensus is beginning to develop that the two pathologies are not separate processes, and the Wnt signalling pathway may provide a pathological link between both. In fact, work in transgenic mice showed that A beta or the amyloid precursor protein can influence the formation of Tau tangles in areas of the brain known to be affected in AD. Furthermore, A beta can contribute to synaptic dysfunction. Thus, A beta appears to be a recurring player affecting protein phosphorylation, signal transduction mechanisms, cytoskeletal organization, multiprotein complex formation, synaptotoxicity and ultimately culminating in protein aggregation. Consequently this peptide and the downstream signalling cascades are presently considered as potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942790     DOI: 10.2174/187152710793237458

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  9 in total

1.  Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β.

Authors:  Nicole Schonrock; David T Humphreys; Thomas Preiss; Jürgen Götz
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

2.  Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.

Authors:  Kimberly Luttik; Leon Tejwani; Hyoungseok Ju; Terri Driessen; Cleo J L M Smeets; Chandrakanth Reddy Edamakanti; Aryaan Khan; Joy Yun; Puneet Opal; Janghoo Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

Review 3.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

4.  Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.

Authors:  Monika Zaręba-Kozioł; Agnieszka Szwajda; Michał Dadlez; Aleksandra Wysłouch-Cieszyńska; Maciej Lalowski
Journal:  Mol Cell Proteomics       Date:  2014-06-03       Impact factor: 5.911

5.  Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.

Authors:  Ana de la Encarnación; Carolina Alquézar; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

6.  Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of γ-secretase complex.

Authors:  Zhiyou Cai; Yingjun Zhou; Zhou Liu; Zunyu Ke; Bin Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-17       Impact factor: 2.570

Review 7.  Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.

Authors:  Catarina Domingues; Odete A B da Cruz E Silva; Ana Gabriela Henriques
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

8.  Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways.

Authors:  Li Zeng; Dapeng Zhang; Hayley S McLoughlin; Annie J Zalon; L Aravind; Henry L Paulson
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

9.  Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.

Authors:  Amir M Hossini; Matthias Megges; Alessandro Prigione; Bjoern Lichtner; Mohammad R Toliat; Wasco Wruck; Friederike Schröter; Peter Nuernberg; Hartmut Kroll; Eugenia Makrantonaki; Christos C Zouboulis; Christos C Zoubouliss; James Adjaye
Journal:  BMC Genomics       Date:  2015-02-14       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.